Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34- and immature CD34+ cells.
Berger MG, Lebecque B, Tassin T, Dannus LT, Berger J, Soucal M, Guerci A, Cony-Makhoul P, Johnson H, Etienne G, Guyotat D, Gagnieu MC, Pereira B, Saugues S, Tournilhac O, Hermet E, Bourgne C.
Berger MG, et al. Among authors: lebecque b.
Sci Rep. 2021 Mar 17;11(1):6187. doi: 10.1038/s41598-021-85734-0.
Sci Rep. 2021.
PMID: 33731863
Free PMC article.